Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol discontinuation regimens for infantile hemangioma relapse
ChiCTR2000033415Phase 4Not yet recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propranolol in Capillary Haemangioma (4 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: Minor relapse. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on ChiCTR2000033415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033415.